விண்டன் மையம் க்கு ஆபத்து இல் கேம்பிரிட்ஜ் பல்கலைக்கழகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Benefits of AstraZeneca vaccine outweigh risks 22 Apr 2021 | 4 mins (including 1 min video)   Risk versus benefit modelling by researchers at The University of Western Australia has weighed up the potential of harm from an extremely rare AstraZeneca vaccine blood clot complication against COVID-19 ICU admission from not being vaccinated. Associate Professor Matthew Linden from UWA’s School of Biomedical Sciences said the modelling had identified the implications for each adult age group of waiting out the months it might take Australia to secure further supplies of an alternative vaccine. Based on Australia’s recent low risk of COVID exposure and a possible delay of 16 weeks for an alternative vaccine, the results suggested only under 50-year-olds should consider “holding out” for an alternative vaccine. For them, there was no clear benefit from AstraZeneca vaccination when virus transmission was low.

Matthew lindenSchool of biomedical sciencesWinton centre for risk at cambridge universityUniversity of western australiaWestern australiaProfessor matthew lindenBiomedical sciencesProfessor matthewWinton centreCambridge universityProfessor lindenWest australiansமேத்யூ லிண்டன்பள்ளி ஆஃப் உயிர் மருத்துவ அறிவியல்விண்டன் மையம் க்கு ஆபத்து இல் கேம்பிரிட்ஜ் பல்கலைக்கழகம்பல்கலைக்கழகம் ஆஃப் மேற்கு ஆஸ்திரேலியா